Company Name, Ticker, Competitors, else..

Oncosec Medical Incorporated (NASDAQ: ONCS)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Oncosec Medical Incorporated's

Name: Oncosec Medical Incorporated Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONCS Sales vs. its Competitors Q2 2022

Comparing the current results to its competitors, Oncosec Medical Incorporated reported Revenue decrease in the 2 quarter 2022 year on year by 0 %, despite the revenue increase by the most of its competitors of 4.08 %, recorded in the same quarter.

• List of ONCS Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Oncosec Medical Incorporated, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< ONCS Stock Performance Comparisons

<< See the full list of ONCS competitors

*Market share is calculated based on total revenue.

ONCS's Stock Performance relative to its Competitors

Publicly Traded Peers of Oncosec Medical Incorporated

Kineta Inc
Share Performance

0.00%

One Year

Kineta Inc

Profile

Kineta, Inc. conducts its business primarily through Private Kineta's operations following a merger.

More about Kineta Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4.336 mill.	$ 0.500 mill.	$ -8.463 mill.

Nurix Therapeutics Inc
Share Performance

-3.14%

30 Days

Nurix Therapeutics Inc

Profile

Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels.

More about Nurix Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2,865.423 mill.	$ 36.766 mill.	$ -341.351 mill.

Nuvalent Inc
Share Performance

+48.63%

One Year

Nuvalent Inc

Profile

Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise.

More about Nuvalent Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 9,751.979 mill.	$ - mill.	$ -450.074 mill.

Nuvectis Pharma inc
Share Performance

+134.18%

This Quarter

Nuvectis Pharma inc

Profile

Nuvectis Pharma Inc's business model appears to focus on the development and commercialization of pharmaceutical products.

More about Nuvectis Pharma inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 538.774 mill.	$ - mill.	$ -30.275 mill.

Nextcure Inc
Share Performance

-43.60%

This Year

Nextcure Inc

Profile

NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need.

More about Nextcure Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 39.770 mill.	$ - mill.	$ -42.748 mill.

121 more competitors available

Sources: Oncosec Medical Incorporated’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:57 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Oncosec Medical Incorporated versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.